The Global Needle-Free Injection Market Size gathered USD 1.2 Billion in 2021 and is set to garner a market size of USD 2.6 Billion by 2030 growing at a CAGR of 9.7% from 2022 to 2030.

Needle-free injections are a type of drug delivery system in which medication is delivered through the skin without the use of a needle using high-pressure, jet injectors. They penetrate the skin with a fine, high-speed stream of fluid and deliver the medication into the body. The pain associated with traditional needle injections is eliminated with needle-free injections. Needle-free injections can enhance patient compliance with treatment regimens by removing the fear and discomfort associated with needle injections. In addition, these injections eliminate the risk of needle-stick injuries, which could be a major concern for both healthcare workers and patients. When compared to traditional needle injections, they may be more accurate in delivering the correct dose of medication. Furthermore, needle-free injection systems can be administered by non-medical personnel or self-administered, making them more convenient for patients and healthcare providers.

Needle-Free Injection Market Report Statistics

• Global needle-free injection market revenue is estimated to reach USD 2.6 Billion by 2030 with a CAGR of 9.7% from 2022 to 2030
• North America needle-free injection market value gathered more than USD 475.6 million in 2021
• Asia-Pacific needle-free injection market growth will record a CAGR of more than 10% from 2022 to 2030
• Among products, the fillable sub-segment collected around 71% share in 2021
• Based on technology, the spring-based needle-free injectors sub-segment achieved US$ 498.8 million in revenue in 2021
• The increasing adoption of wearable needle-free injectors is a popular needle-free injection market trend that drives the industry demand

Global Needle Free Injection Market Dynamics

Market Drivers

• Increasing prevalence of chronic disorders
• Growing awareness about the benefits of needle-free injections
• Rising demand for pain-free and convenient administration of medications
• Growing focus on patient safety and comfort

Market Restraints

• High cost of these injections
• Regulatory hurdles
• Limited penetration in developing countries

Market Opportunities

• Favorable government support
• Expansion of home healthcare services
• Rising demand for needle-free injectors for vaccines
• Technological advancements in the healthcare industry

Needle-Free Injection Market Report Coverage

Market	Needle-Free Injection Market
Needle-Free Injection Market Size 2021	USD 1.2 Billion
Needle-Free Injection Market Forecast 2030	USD 2.6 Billion
Needle-Free Injection Market CAGR During 2022 - 2030	9.7%
Needle-Free Injection Market Analysis Period	2018 - 2030
Needle-Free Injection Market Base Year	2021
Needle-Free Injection Market Forecast Data	2022 - 2030
Segments Covered	By Product, By Type, By Technology, By Usability, By Delivery Site, By Application, By End-Use, And By Geography
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	Aijex Pharma International Inc., Antares Pharma, Inc, Crossject, Ferring B.V., Inovio Pharmaceuticals, Medical International Technology Inc., NuGen Medical Devices, Penjet Corporation, PharmaJet, and Portal Instruments.
Report Coverage	Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis

Needle-Free Injection Systems Market Growth Factors

The rising prevalence of chronic diseases such as diabetes, cancer, and cardiovascular disease is driving the needle-free injection market. Another factor driving the needle-free injection systems market is the rising demand for pain-free and convenient medication administration. Needle-free injections are becoming increasingly popular because they are a painless and convenient alternative to traditional needle injections. Furthermore, growing awareness of the benefits of needle-free injections, such as the reduced risk of needle-stick injuries and enhance patient compliance, is increasing the needle-free injection systems market value.

However, needle-free injection systems can be more expensive compared to traditional needle injections, which can be a barrier to their adoption, particularly in developing countries. In addition to that, the approval process for needle-free injection systems can be lengthy and complex, requiring extensive clinical trials and regulatory approval, which can slow down market growth. There is also a lack of standardization in the design and function of needle-free injection systems, which can lead to confusion and unpredictability in their performance. Furthermore, these systems have limited penetration in developing countries, where traditional needle injections are still widely used.

Needle Free Injection Systems Market Segmentation

The worldwide needle-free injection market is categorized based on product, type, technology, usability, delivery site, application, end-use, and geography.

Needle-Free Injection Market By Product

• Fillable
• Prefilled

Our needle-free injection industry analysis found that the fillable sub-segment would dominate the market in 2021. The needle-free injection industry was dominated by fillable needle-free injection systems, also known as reusable or multi-dose needle-free injections. Fillable systems are designed to be refilled with medication after each use, making them a less expensive option than disposable needle-free injections. Fillable needle-free injection systems are widely used in the administration of medications that require frequent injections, such as insulin, and are also used in hospitals and other healthcare facilities. Fillable needle-free injection systems dominate due to their low cost and versatility, making them a popular choice among healthcare providers and patients.

Needle-Free Injection Market By Type

• Liquid-Based Needle Free Injectors
• Powder-Based Needle Free Injectors
• Projectile/Depot-Based Needle Free Injectors

Compared to other varieties of needle-free injectors, such as powder-based and gas-based injectors, liquid-based injectors hold a sizable portion of the needle-free injection market. Liquid-based needle-free injectors are the most commonly used type of needle-free injectors, due to their ability to deliver a range of medications, including vaccines, insulin, and other drugs. They work by passing a fine, high-pressure stream of liquid medication through the skin, allowing the medication to be absorbed without the use of a needle. The ease of use, accuracy, and versatility of liquid-based needle-free injectors have contributed to their popularity among healthcare providers and patients.

Needle-Free Injection Market By Technology

• Gas-Powered Needle-Free Injectors
• Laser-Powered Needle-Free Injectors
• Spring-Based Needle-Free Injectors
• Vibration-Based Needle-Free Injectors

In terms of technology, the gas-powered needle-free injectors sub-segment held the largest market share in 2021. Gas-powered needle-free injectors are a relatively new technology in the needle-free injections market, and they have several benefits over traditional needle-based injections and other types of needle-free injectors. Gas-powered needle-free injectors utilize high-pressure gas to deliver medications, allowing for quick and precise medication administration. Gas-powered needle-free injectors offer a painless alternative to traditional needle-based injections that can improve patient compliance and encourage medication use regularly. In addition, unlike traditional needle-based injections, gas-powered needle-free injectors do not generate hazardous waste, making them a more environmentally friendly option.

Needle-Free Injection Market By Usability

• Disposable
• Reusable

According to our needle-free injections market forecast, reusable usability will lead the market from 2022 to 2030. Reusable needle-free injectors are intended to be refilled with medication after each use, making them a less expensive option than disposable needle-free injections. They are widely used in the administration of medications that require frequent injections, such as insulin, and are also used in hospitals and other healthcare facilities. Reusable needle-free injectors are popular due to their low cost and versatility, making them a popular choice among healthcare providers and patients.

Needle-Free Injection Market By Delivery Site

• Intradermal
• Intramuscular
• Subcutaneous

The needle-free injection market is dominated by subcutaneous needle-free injectors. Subcutaneous needle-free injections are intended to deliver medications into the subcutaneous tissue, which is located beneath the skin and above the muscle. This type of needle-free injection is commonly used to administer medications like insulin, vaccines, and other drugs that are meant to be absorbed slowly and continuously over time. Subcutaneous needle-free injections are popular due to their ease of use, safety, and effectiveness, making them a popular choice among healthcare providers and patients.

Needle-Free Injection Market By Application

• Insulin Delivery
• Pain Management
• Vaccine Delivery
• Others

Vaccine delivery is a significant application of needle-free injectors and is expected to account for a sizable portion of the needle-free injections market between 2022 and 2030. Because of the growing demand for pain-free and convenient vaccine administration, the use of needle-free injectors for vaccine delivery is rapidly increasing. Needle-free injectors are used to deliver a variety of vaccines, including influenza, hepatitis, and others, and are a more comfortable alternative to traditional needle-based injections. The growing use of needle-free injectors for vaccine delivery is expected to drive future needle-free injection market growth.

Needle-Free Injection Market By End-Use

• Hospitals & Clinics
• Home Care Settings
• Research Laboratories

Based on our needle-free injection market analysis, the hospitals and clinics sub-segment occupied the largest market share in 2021 and is likely to do so in the coming years. In hospitals and clinics, needle-free injectors are commonly used to deliver medications such as insulin, vaccines, and other drugs. The growing demand for pain-free and convenient medication and vaccine administration in hospitals and clinics is expected to drive the needle-free injectors market in this end-use segment. Furthermore, the growing emphasis on patient safety and comfort, as well as the rising demand for home healthcare services, are expected to drive future growth in the needle-free injectors market in hospitals and clinics.

Needle-Free Injection Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Needle-Free Injection Market Regional Analysis

The needle-free injection systems market in North America is expected to expand significantly in the coming years due to rising demand for pain-free and convenient medication and vaccine administration. The presence of advanced healthcare infrastructure and a large patient pool is expected to drive growth in the North American needle-free injection systems market. The United States is the largest market in North America for needle-free injections, followed by Canada.

The Asia-Pacific needle-free injection systems market is expected to expand significantly in the coming years due to rising demand for pain-free and convenient medication and vaccine administration. The rising prevalence of chronic diseases, rising adoption of needle-free injectors for the delivery of insulin and other medications, and rising awareness about the benefits of needle-free injections are expected to drive the Asia-Pacific needle-free injection systems market.

Needle-Free Injection Market Players

Some of the leading Needle-Free Injection companies include Aijex Pharma International Inc., Antares Pharma, Inc, Crossject, Ferring B.V., Inovio Pharmaceuticals, Medical International Technology Inc., NuGen Medical Devices, Penjet Corporation, PharmaJet, and Portal Instruments.

TABLE OF CONTENT